LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for Ulcerative Colitis
Drug: LY4268989
41 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07186101·Phase 2·Recruiting